课题基金 / 基金详情

PRE-SURGICAL DETECTION OF COLORECTAL CARCINOMAS USING INDIUM-DOTA-CT8466 MINIBO

PRE-SURGICAL DETECTION OF COLORECTAL CARCINOMAS USING INDIUM-DOTA-CT8466 MINIBO
使用 Indium-DOTA-CT8466 MINIBO 对结直肠癌进行术前检测
批准号:
7603872
负责人:
JEFFREY Y WONG
金额:
$10.37万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

JEFFREY Y WONG的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 本研究的主要目的是确定In-DOTA-cT84.66微抗体片段定位于结直肠癌的能力,如通过定量放射免疫闪烁照相术和活检样品所确定的。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to determine the ability of In-DOTA-cT84.66 minibody fragments to localize to colorectal cancer, as determined by quantitative radioimmunoscintigraphy and biopsy samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
A PHASE I STUDY OF A COMBINATION OF YTTRIUM-90 LABELED HUMANIZED ANTI-CEA M5A
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC
海外基金